Priority Date: 18.04.08 (US 20080046158P)

Predicting risk of major adverse cardiac events

  • Application ID: EP14177846
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Attorney

operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) and G01 (MEASURING; TESTING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Weidner Stern Jeschke, Zacco Denmark A/S and 92 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 18.04.2008 - Priority Date (US 20080046158P)
  • 21.01.2015 - Publication A1 (EP2827152)
  • 08.06.2016 - Publication B1 (EP2827152)

IPC Classification